EICHOR

Recruiting studies: Extensive Stage Sclc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adul
Phase 2/Phase 3 · 73 location(s) · Pfizer · NCT07226999 Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).
Phase 2 · 25 location(s) · Gruppo Oncologico Italiano di Ricerca Clinica · NCT06663098 Liposomal Irinotecan and Apatinib in ES-SCLC
Phase 2 · 1 location(s) · Second Affiliated Hospital, Zhejiang University, School of M · NCT06749691 Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLC
Phase N/A · 1 location(s) · Henan Cancer Hospital · NCT07244016 Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy
NA · 1 location(s) · Ruijin Hospital · NCT05552846 A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in
Phase 1/Phase 2 · 58 location(s) · Daiichi Sankyo · NCT06362252 Second-line Immunotherapy for ES-SCLC
NA · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06853678 Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) a
Phase 1/Phase 2 · 43 location(s) · National Cancer Institute (NCI) · NCT06287775 Talazoparib and Thoracic RT for ES-SCLC
Phase 1 · 1 location(s) · University Health Network, Toronto · NCT04170946 Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Phase N/A · 11 location(s) · Tempus AI · NCT05257551 The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
NA · 2 location(s) · University of Colorado, Boulder · NCT07636200 A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors
Phase 2 · 8 location(s) · Shanghai AB PharmaTech Ltd. · NCT07321574 Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer
Phase N/A · 3 location(s) · Qingdao Central Hospital · NCT06514118 Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
Phase N/A · 2 location(s) · Oncology Center of Biochemical Education And Research · NCT06717243 Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
Phase 1/Phase 2 · 1 location(s) · Sichuan University · NCT06217757 Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Tr
Phase 2 · 1 location(s) · Shanghai Chest Hospital · NCT06698965 A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Th
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07358676 SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer
Phase 1/Phase 2 · 1 location(s) · SN BioScience · NCT07391813 PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer
Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06429696 A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab
Phase 3 · 2 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT07502300 First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy
Phase 2 · 1 location(s) · Nir Peled · NCT06667167 Adebrelimab + Apatinib in SCLC Maintenance Therapy
Phase 2 · 1 location(s) · Tang-Du Hospital · NCT06475209 AGNOSTIC THERAPY IN A PHASE II SINGLE-ARM STUDY IN FIRST-LINE TREATMENT OF DURVALUMAB IN ASSOCIATION WITH CARBOPLATIN OR
Phase 2 · 1 location(s) · Gruppo Oncologico Italiano di Ricerca Clinica · NCT06464068 Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer
Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT04696575 A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06954246 WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
Phase 1/Phase 2 · 1 location(s) · Fudan University · NCT06243003 First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC
Phase 2 · 1 location(s) · Xiaorong Dong · NCT05745350 Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC
Phase 1/Phase 2 · 2 location(s) · Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. · NCT07136285 A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizum
Phase 1 · 1 location(s) · Peking University Cancer Hospital & Institute · NCT07413042 A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311
Phase 1 · 19 location(s) · Amgen · NCT07037758

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →